Not recruitingISRCTN23032339
A randomised, double-blind, placebo-controlled trial to evaluate the efficacy and tolerability of olanzapine as adjunctive treatment for Eating disorders in touth: a pilot study
Research studyAges 12–17Canada
Understand this study
Who could participate?
Listed age limits: 12 years to 17 years.
- Listed locations
- Canada
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Children's Hospital of Eastern Ontario (Canada)
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Canada
- Age range
- From 12 Years to 17 Years
- Official registry ID
- ISRCTN23032339
- Official title
Show the full official title
A randomised, double-blind, placebo-controlled trial to evaluate the efficacy and tolerability of olanzapine as adjunctive treatment for Eating disorders in touth: a pilot study
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Children's Hospital of Eastern Ontario (Canada), a hospital or academic medical center.
Who can participate?
Listed age limits: 12 years to 17 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
